Going back to the IIH incidence rates, this is from the IXC presentation slides.
2016 is 6-7 years ago now, with a strong trend of increasing IIH incidence rates growing for the prior 16 years within the chart being identified. The highlighted points show what 7 years difference is from 2008 to 2016, to try highlight the difference between 2016 and 2023 and what they may be. Between 2008 and 2016, the incidence went from ~4.1 to ~7.8.
Now, I wonder what the last 6-7 years (2016-2022) has done to the IIH incidence rate inputs. If we continue that rate of growth, ~10-12 looks inevitable?
The original DCF posted above uses 4.7 per 100,000 for context... that is a major bear case looking that this chart and projecting it forward?
I know we talked about this before, but what are our final thoughts on a 2 point window@SSilverstein & @jellyroll?
Incidence rates of 6-8 (as per 2014-2016 to stay conservative) or is 8-10 or even 10-12 reasonable?
- Forums
- ASX - By Stock
- IXC
- DCF Valuation Model for Invex Therapeutics
DCF Valuation Model for Invex Therapeutics, page-76
-
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.062 |
1 | 15500 | 0.061 |
1 | 150000 | 0.060 |
1 | 100000 | 0.052 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 10000 | 1 |
0.069 | 16500 | 1 |
0.070 | 40000 | 1 |
0.076 | 888 | 1 |
0.083 | 4000 | 1 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable